annual CFF:
$273.11M+$153.89M(+129.07%)Summary
- As of today (June 22, 2025), BPMC annual cash flow from financing activities is $273.11 million, with the most recent change of +$153.89 million (+129.07%) on December 31, 2024.
- During the last 3 years, BPMC annual CFF has risen by +$222.40 million (+438.51%).
- BPMC annual CFF is now -55.79% below its all-time high of $617.76 million, reached on December 31, 2020.
Performance
BPMC Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$9.19M-$567.00K(-5.81%)Summary
- As of today (June 22, 2025), BPMC quarterly cash flow from financing activities is $9.19 million, with the most recent change of -$567.00 thousand (-5.81%) on March 31, 2025.
- Over the past year, BPMC quarterly CFF has dropped by -$57.77 million (-86.27%).
- BPMC quarterly CFF is now -97.58% below its all-time high of $380.56 million, reached on September 30, 2022.
Performance
BPMC quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$215.34M-$57.77M(-21.15%)Summary
- As of today (June 22, 2025), BPMC TTM cash flow from financing activities is $215.34 million, with the most recent change of -$57.77 million (-21.15%) on March 31, 2025.
- Over the past year, BPMC TTM CFF has increased by +$29.15 million (+15.66%).
- BPMC TTM CFF is now -66.81% below its all-time high of $648.78 million, reached on March 31, 2020.
Performance
BPMC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BPMC Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +129.1% | -86.3% | +15.7% |
| 3 y3 years | +438.5% | +627.2% | +378.9% |
| 5 y5 years | -19.8% | -97.0% | -66.8% |
BPMC Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -51.4% | +438.5% | -97.6% | >+9999.0% | -62.7% | +378.9% |
| 5 y | 5-year | -55.8% | +438.5% | -97.6% | >+9999.0% | -66.8% | +378.9% |
| alltime | all time | -55.8% | +6031.8% | -97.6% | +1243.3% | -66.8% | +9087.5% |
BPMC Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $9.19M(-5.8%) | $215.34M(-21.2%) |
| Dec 2024 | $273.11M(+129.1%) | $9.76M(-46.9%) | $273.11M(-2.1%) |
| Sep 2024 | - | $18.38M(-89.7%) | $278.88M(-22.3%) |
| Jun 2024 | - | $178.01M(+165.8%) | $358.90M(+92.8%) |
| Mar 2024 | - | $66.96M(+331.2%) | $186.19M(+56.2%) |
| Dec 2023 | $119.22M(-78.8%) | $15.53M(-84.2%) | $119.22M(+12.3%) |
| Sep 2023 | - | $98.40M(+1757.3%) | $106.19M(-72.7%) |
| Jun 2023 | - | $5.30M(>+9900.0%) | $388.35M(-30.7%) |
| Mar 2023 | - | $0.00(-100.0%) | $560.55M(-0.2%) |
| Dec 2022 | $561.81M(+1007.8%) | $2.49M(-99.3%) | $561.81M(-2.7%) |
| Sep 2022 | - | $380.56M(+114.4%) | $577.25M(+178.0%) |
| Jun 2022 | - | $177.50M(>+9900.0%) | $207.61M(+361.7%) |
| Mar 2022 | - | $1.26M(-92.9%) | $44.97M(-11.3%) |
| Dec 2021 | $50.72M(-91.8%) | $17.93M(+64.2%) | $50.72M(-79.9%) |
| Sep 2021 | - | $10.92M(-26.5%) | $252.88M(-22.5%) |
| Jun 2021 | - | $14.85M(+111.9%) | $326.30M(+3.7%) |
| Mar 2021 | - | $7.01M(-96.8%) | $314.62M(-49.1%) |
| Dec 2020 | $617.76M(+81.4%) | $220.09M(+161.0%) | $617.76M(+54.6%) |
| Sep 2020 | - | $84.34M(+2556.4%) | $399.50M(+25.0%) |
| Jun 2020 | - | $3.17M(-99.0%) | $319.65M(-50.7%) |
| Mar 2020 | - | $310.15M(>+9900.0%) | $648.78M(+90.5%) |
| Dec 2019 | $340.64M | $1.83M(-59.2%) | $340.64M(+0.3%) |
| Sep 2019 | - | $4.50M(-98.6%) | $339.57M(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $332.30M(>+9900.0%) | $335.19M(+9749.7%) |
| Mar 2019 | - | $2.01M(+163.2%) | $3.40M(-23.6%) |
| Dec 2018 | $4.45M(-99.2%) | $764.00K(+576.1%) | $4.45M(-98.7%) |
| Sep 2018 | - | $113.00K(-78.1%) | $331.54M(-0.1%) |
| Jun 2018 | - | $515.00K(-83.2%) | $331.80M(-39.4%) |
| Mar 2018 | - | $3.06M(-99.1%) | $547.43M(+0.6%) |
| Dec 2017 | $543.95M(+310.3%) | $327.85M(>+9900.0%) | $543.95M(+55.1%) |
| Sep 2017 | - | $372.00K(-99.8%) | $350.73M(+0.3%) |
| Jun 2017 | - | $216.14M(<-9900.0%) | $349.62M(+163.0%) |
| Mar 2017 | - | -$420.00K(-100.3%) | $132.96M(+0.3%) |
| Dec 2016 | $132.58M(-13.5%) | $134.63M(<-9900.0%) | $132.58M(-5633.3%) |
| Sep 2016 | - | -$731.00K(+41.1%) | -$2.40M(+9.7%) |
| Jun 2016 | - | -$518.00K(-35.6%) | -$2.19M(-101.4%) |
| Mar 2016 | - | -$804.00K(+134.4%) | $152.97M(-0.2%) |
| Dec 2015 | $153.22M(+88.3%) | -$343.00K(-34.0%) | $153.22M(-26.4%) |
| Sep 2015 | - | -$520.00K(-100.3%) | $208.17M(-0.3%) |
| Jun 2015 | - | $154.63M(<-9900.0%) | $208.70M(+273.9%) |
| Mar 2015 | - | -$547.00K(-101.0%) | $55.82M(-31.4%) |
| Dec 2014 | $81.35M(+352.2%) | $54.60M(>+9900.0%) | $81.35M(+204.1%) |
| Sep 2014 | - | $17.00K(-99.0%) | $26.75M(+0.1%) |
| Jun 2014 | - | $1.75M(-93.0%) | $26.73M(+7.0%) |
| Mar 2014 | - | $24.99M | $24.99M |
| Dec 2013 | $17.99M | - | - |
FAQ
- What is Blueprint Medicines annual cash flow from financing activities?
- What is the all time high annual CFF for Blueprint Medicines?
- What is Blueprint Medicines annual CFF year-on-year change?
- What is Blueprint Medicines quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Blueprint Medicines?
- What is Blueprint Medicines quarterly CFF year-on-year change?
- What is Blueprint Medicines TTM cash flow from financing activities?
- What is the all time high TTM CFF for Blueprint Medicines?
- What is Blueprint Medicines TTM CFF year-on-year change?
What is Blueprint Medicines annual cash flow from financing activities?
The current annual CFF of BPMC is $273.11M
What is the all time high annual CFF for Blueprint Medicines?
Blueprint Medicines all-time high annual cash flow from financing activities is $617.76M
What is Blueprint Medicines annual CFF year-on-year change?
Over the past year, BPMC annual cash flow from financing activities has changed by +$153.89M (+129.07%)
What is Blueprint Medicines quarterly cash flow from financing activities?
The current quarterly CFF of BPMC is $9.19M
What is the all time high quarterly CFF for Blueprint Medicines?
Blueprint Medicines all-time high quarterly cash flow from financing activities is $380.56M
What is Blueprint Medicines quarterly CFF year-on-year change?
Over the past year, BPMC quarterly cash flow from financing activities has changed by -$57.77M (-86.27%)
What is Blueprint Medicines TTM cash flow from financing activities?
The current TTM CFF of BPMC is $215.34M
What is the all time high TTM CFF for Blueprint Medicines?
Blueprint Medicines all-time high TTM cash flow from financing activities is $648.78M
What is Blueprint Medicines TTM CFF year-on-year change?
Over the past year, BPMC TTM cash flow from financing activities has changed by +$29.15M (+15.66%)